Riskpilot← Back to searchSign inGet full accessHealz AB
ABActiveOrg 5593517468Storgatan 18Medical specialists activities · NACE 8622Est. 20210 employees
Revenue 2025
SEK 106K
-67% vs 2024
EBITDA margin
73.9%
-73% vs 2024
Equity ratio
80.8%
Financial strength
Net profit 2025
SEK 61K
-74% vs 2024
| Revenue | SEK 106K | -67% |
| EBITDA | SEK 78K | -73% |
| Net profit | SEK 61K | -74% |
| Total assets | SEK 182K | -58% |
| Equity | SEK 147K | -49% |
| Employees | 0 | — |
Legal name
Healz AB
Org number
5593517468
Legal form
Aktiebolag
NACE code
8622 · Medical specialists activities
Founded
7 december 2021
Share capital
SEK 25 000
Employees
0
VAT registered
Yes
Audit selected
No
Last report
2025-09-30
Financial year
January – December
Signatory rights
Firman tecknas av styrelsen Registrerad särskild delgivningsmottagare saknas. Då minst halva antalet styrelseledamöter och minst halva antalet styrelsesuppleanter ska vara bosatta inom EES uppfyller företaget inte kravet på bosättning.
Company purpose
Bolaget ska bedriva läkarkonsultverksamhet inom Sverige samt därmed förenlig verksamhet.
Address
Storgatan 18
Risika for professionals
Risika provides regulated workflow tools for finance, procurement and compliance teams that need monitoring, alerts and an API.
| Item | 2022 | 2023 | 2024 | 2025 |
|---|---|---|---|---|
| Revenue | 285 | 297 | 321 | 106 |
| Staff expenses | — | — | −0 | −0 |
| EBITDA | 261 | 255 | 294 | 78 |
| Depreciation & amort. | — | — | — | — |
| EBIT | 261 | 255 | 294 | 78 |
| Net financials | −0 | 0 | 0 | −1 |
| Profit before tax | 261 | 256 | 294 | 77 |
| Tax | −54 | −53 | −60 | −16 |
| Net profit | 207 | 203 | 233 | 61 |
| Item | 2022 | 2023 | 2024 | 2025 |
|---|---|---|---|---|
| Total assets | 317 | 341 | 429 | 182 |
| Equity | 232 | 248 | 286 | 147 |
| Long-term debt | — | — | — | — |
| Short-term debt | 85 | 93 | 143 | 35 |
| Total debt | 85 | 93 | 143 | 35 |
EBITDA margin
73.9%
This company
15.8%
Market median
+368% vs market
20222025
Equity ratio
80.8%
This company
38.2%
Market median
+112% vs market
20222025
Return on equity
41.7%
This company
18.4%
Market median
+127% vs market
20222025
Net profit margin
58.1%
This company
8.1%
Market median
+617% vs market
20222025
Asset turnover
0.58×
This company
1.12×
Market median
-48% vs market
20222025
Debt / equity
0.24×
This company
0.62×
Market median
+61% vs market
20222025
- Annual report 2025Filed via Bolagsverket / SCB · Period 2024-10-01 – 2025-09-30
- Annual report 2024Filed via Bolagsverket / SCB · Period 2023-10-01 – 2024-09-30
- Annual report 2023Filed via Bolagsverket / SCB · Period 2022-10-01 – 2023-09-30
- Annual report 2022Filed via Bolagsverket / SCB · Period 2021-12-07 – 2022-09-30
No data on file.
| Name | Role | Member since |
|---|---|---|
| Current (2) | ||
| Deputy Board Member | 2022 | |
| Board of Directors | 2022 | |
No shareholder data available.
Beneficial ownership (UBO) data access is restricted in Denmark as of September 2025 per the EU 6th AML Directive. Learn more.
No registered parent or subsidiaries
Board members of Healz AB also hold positions in 0 other companies.
| Person | Role here | Other companies |
|---|---|---|
| Rima Smidi | Deputy Board Member | 0 companies |
| Ahmad El Hage | Board of Directors | 0 companies |